27.40
1.89 (7.41%)
1.89 (7.41%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Apellis Pharmaceuticals Inc | APLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 1.89 | 7.41% | 27.40 | 25.40 | 27.73 | 25.75 | 25.51 | 15:20:24 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 27.40 | 27.48 | 0.08 | 0.29% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,253 | 399,129 | $ 26.63 | $ 10,630,133 | 1,080,175 | 16.85 - 50.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:20:24 | 29 | $ 27.41 | USD |
Apellis Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 2.06B | 75.32M | $ -127.50M | -5.20 | - | 71.59M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 39.00 | 5.00% |
Apellis Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APLS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 26.98 | 28.36 | 24.3435 | 25.83 | 669,158 | 0.42 | 1.56% |
| 1 Month | 30.74 | 31.09 | 16.85 | 24.65 | 1,055,970 | -3.34 | -10.87% |
| 3 Months | 41.47 | 45.04 | 16.85 | 33.47 | 960,270 | -14.07 | -33.93% |
| 6 Months | 23.66 | 50.00 | 16.85 | 33.67 | 1,250,205 | 3.74 | 15.81% |
| 1 Year | 20.17 | 50.00 | 16.85 | 31.60 | 822,826 | 7.23 | 35.85% |
| 3 Years | 14.50 | 50.00 | 11.45 | 27.51 | 503,899 | 12.90 | 88.97% |
| 5 Years | 14.50 | 50.00 | 11.45 | 27.51 | 503,899 | 12.90 | 88.97% |
Apellis Pharmaceuticals Description
| Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade. |
